In addition, while PKCα-KR CLL exhibits increased RAP sensitivity, in terms of reducing tumour load in vivo, all CLL models displayed similar functional responses to AZD8055 and RAP. The gene discussed is PRKCA; the disease is B-cell chronic lymphocytic leukemia.